Estradiol valerate/dienogest

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 10:37, 24 June 2019. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Estradiol valerate / dienogest
Estradiol valerate (top) and
dienogest (bottom)
Combination of
Estradiol valerateEstrogen
DienogestProgestogen
Clinical data
Trade namesLafamme, Natazia, Qlaira
Other namesEV/DNG; SH T00658ID; Bay 86-5027; BAY86-5027
Routes of
administration		By mouth
Drug classEstrogen; Progestogen
Legal status
Legal status
Identifiers
CAS Number
PubChem CID

Estradiol valerate/dienogest (EV/DNG), sold under the brand names Lafamme, Natazia and Qlaira among others, is a combination product of estradiol valerate, an estrogen, and dienogest, a progestogen, which is used in menopausal hormone therapy in and as a birth control pill to prevent pregnancy in women. It is taken by mouth.

Birth control pills containing EV/DNG are associated with a significantly increased risk of venous thromboembolism.[1] However, they are associated with a significantly lower risk of venous thromboembolism than birth control pills containing ethinylestradiol and a progestin.[1]

See also

References

  1. ^ a b Fruzzetti F, Cagnacci A (2018). "Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?". Open Access J Contracept. 9: 75–79. doi:10.2147/OAJC.S179673. PMC 6239102. PMID 30519125.{{cite journal}}: CS1 maint: unflagged free DOI (link)



Stub icon

This article about a steroid is a stub. You can help Wikipedia by expanding it.

Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Estradiol_valerate/dienogest&oldid=903222154"